162 related articles for article (PubMed ID: 15533889)
1. Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases.
Chung AW; Radomski A; Alonso-Escolano D; Jurasz P; Stewart MW; Malinski T; Radomski MW
Br J Pharmacol; 2004 Dec; 143(7):845-55. PubMed ID: 15533889
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of proteinase-activated receptor agonists on human platelets.
Chung AW; Jurasz P; Hollenberg MD; Radomski MW
Br J Pharmacol; 2002 Mar; 135(5):1123-32. PubMed ID: 11877318
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
4. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.
Radomski A; Jurasz P; Sanders EJ; Overall CM; Bigg HF; Edwards DR; Radomski MW
Br J Pharmacol; 2002 Dec; 137(8):1330-8. PubMed ID: 12466243
[TBL] [Abstract][Full Text] [Related]
5. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
Martinez A; Salas E; Radomski A; Radomski MW
Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
[TBL] [Abstract][Full Text] [Related]
8. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
Alonso-Escolano D; Strongin AY; Chung AW; Deryugina EI; Radomski MW
Br J Pharmacol; 2004 Jan; 141(2):241-52. PubMed ID: 14691052
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.
Fernandez-Patron C; Martinez-Cuesta MA; Salas E; Sawicki G; Wozniak M; Radomski MW; Davidge ST
Thromb Haemost; 1999 Dec; 82(6):1730-5. PubMed ID: 10613662
[TBL] [Abstract][Full Text] [Related]
13. On the origin of matrix metalloproteinase-2 and -9 in blood platelets.
Wrzyszcz A; Wozniak M
Platelets; 2012; 23(6):467-74. PubMed ID: 22646815
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine priming reduces ADP-induced P-selectin expression and platelet-leukocyte aggregation.
Huang GS; Lin TC; Wang JY; Ku CH; Ho ST; Li CY
Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):56-61. PubMed ID: 19527965
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets.
Harmon S; Inkielewicz-Stepniak I; Jones M; Ledwidge M; Santos-Martinez MJ; Medina C; Radomski MW; Gilmer JF
J Pharm Pharmacol; 2012 Jan; 64(1):77-89. PubMed ID: 22150675
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.
Wang W; Viappiani S; Sawicka J; Schulz R
Br J Pharmacol; 2005 May; 145(1):43-9. PubMed ID: 15711589
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome.
Gries A; Herr A; Kirsch S; Günther C; Weber S; Szabo G; Holzmann A; Böttiger BW; Martin E
Crit Care Med; 2003 Jun; 31(6):1697-704. PubMed ID: 12794407
[TBL] [Abstract][Full Text] [Related]
20. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.
Chen HT; Tsou HK; Tsai CH; Kuo CC; Chiang YK; Chang CH; Fong YC; Tang CH
J Cell Physiol; 2010 Jun; 223(3):737-45. PubMed ID: 20175118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]